Literature DB >> 1287819

Isolated severe thrombocytopenia and bleeding caused by piperacillin.

E Olivera1, P Lakhani, C Watanakunakorn.   

Abstract

Bleeding and severe thrombocytopenia developed in a 71-year-old man who had been receiving piperacillin 5 g intravenously every 8 h for 9 days for the treatment of Pseudomonas aeruginosa septicemia. After piperacillin was discontinued, the platelet counts became normal. Rechallenge was made with 2 g of piperacillin intravenously resulting in thrombocytopenia within 6 h of piperacillin administration. The platelet count normalized after 3 days when no further piperacillin was given.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1287819     DOI: 10.3109/00365549209062471

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  6 in total

Review 1.  Drug-induced thrombocytopenia in the coronary care unit.

Authors:  N M Patnode; P J Gandhi
Journal:  J Thromb Thrombolysis       Date:  2000-10       Impact factor: 2.300

2.  Recurrent acute thrombocytopenia in the hospitalized patient: sepsis, DIC, HIT, or antibiotic-induced thrombocytopenia.

Authors:  Talla A Rousan; Ibrahim T Aldoss; Benjamin D Cowley; Brian R Curtis; Daniel W Bougie; Richard H Aster; James N George
Journal:  Am J Hematol       Date:  2010-01       Impact factor: 10.047

3.  Piperacillin/tazobactam Induced Myelosuppression.

Authors:  Kirsty Wai Chung Lee; Kai Ming Chow; Natalie Pui Ha Chan; Angeline Oi Shan Lo; Cheuk Chun Szeto
Journal:  J Clin Med Res       Date:  2009-03-24

4.  Piperacillin/tazobactem induced epistaxis- A case report.

Authors:  Gaurav Singh Tomar; Rahul Subhash Agrawal; Vivek Baliram Kalyankar; Sonali Chawla; Akhilesh Kumar Tiwari
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2012-07

5.  Piperacillin induced bone marrow suppression: a case report.

Authors:  Ashish Kumar; Gourdas Choudhuri; Rakesh Aggarwal
Journal:  BMC Clin Pharmacol       Date:  2003-06-05

6.  Alternative diagnosis to heparin-induced thrombocytopenia in two critically ill patients despite a positive PF4/heparin-antibody test.

Authors:  Gregor Hron; Folke Knutson; Thomas Thiele; Karina Althaus; Christoph Busemann; Sigrun Friesecke; Andreas Greinacher; Norbert Lubenow
Journal:  Ups J Med Sci       Date:  2013-11       Impact factor: 2.384

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.